|
|
||||||||
1 Institute of Biology, National Center for Scientific Research "Demokritos," 15310 Agia Paraskevi, Athens, Greece; 2 Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892; and 3 Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota 55455
In cultured human
glomerular epithelial cells (HGEC), 25 mM glucose resulted in decreased
expression of
3-,
2-, and
1-integrins and increased expression of
5- and
v
3-integrins. This
change was accompanied by decreased binding of HGEC to type IV
collagen. In the presence of normal (5 mM) glucose concentration, cell
binding to type IV collagen was primarily mediated by
2
1- and
5
1-integrins, as indicated by experiments
in which cell adhesion to type IV collagen was competed by specific
anti-integrin monoclonal antibodies. In the presence of high (25 mM)
glucose, the upregulated
5- and
v
3-integrins were mainly involved in cell
binding to type IV collagen. Furthermore, high glucose decreased
expression of matrix metalloproteinase-2 (MMP-2), a collagenase
regulated in part by
3
1-integrin, as
suggested by the use of ligand-mimicking antibodies against these
integrins, which resulted in release of increased amounts of MMP-2 in
the culture medium. Finally, tissue inhibitor of metalloproteinase-2,
the specific inhibitor of MMP-2, was upregulated in high glucose and
could contribute to matrix accumulation. These changes could help
explain basement membrane thickening in diabetes.
matrixins; tissue inhibitors of metalloproteinases; signaling; diabetes
This article has been cited by other articles:
![]() |
C. Dessapt, M. O. Baradez, A. Hayward, A. Dei Cas, S. M. Thomas, G. Viberti, and L. Gnudi Mechanical forces and TGF{beta}1 reduce podocyte adhesion through {alpha}3{beta}1 integrin downregulation Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2645 - 2655. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. I. Drossopoulou, N. E. Tsotakos, and E. C. Tsilibary Impaired transcription factor interplay in addition to advanced glycation end products suppress podocalyxin expression in high glucose-treated human podocytes Am J Physiol Renal Physiol, September 1, 2009; 297(3): F594 - F603. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Asbun and F. J. Villarreal The Pathogenesis of Myocardial Fibrosis in the Setting of Diabetic Cardiomyopathy J. Am. Coll. Cardiol., February 21, 2006; 47(4): 693 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Pedchenko, S. V. Chetyrkin, P. Chuang, A.-J. L. Ham, M. A. Saleem, P. W. Mathieson, B. G. Hudson, and P. A. Voziyan Mechanism of Perturbation of Integrin-Mediated Cell-Matrix Interactions by Reactive Carbonyl Compounds and Its Implication for Pathogenesis of Diabetic Nephropathy Diabetes, October 1, 2005; 54(10): 2952 - 2960. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wolf, S. Chen, and F. N. Ziyadeh From the Periphery of the Glomerular Capillary Wall Toward the Center of Disease: Podocyte Injury Comes of Age in Diabetic Nephropathy Diabetes, June 1, 2005; 54(6): 1626 - 1634. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Economou, P. V. Kitsiou, A. K. Tzinia, E. Panagopoulou, E. Marinos, D. B. Kershaw, D. Kerjaschki, and E. C. Tsilibary Enhanced podocalyxin expression alters the structure of podocyte basal surface J. Cell Sci., July 1, 2004; 117(15): 3281 - 3294. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |